SKYE News

Securities Lawsuit Alert: Skye Bioscience, Inc. (SKYE) - Contact Levi & Korsinsky Before January 16, 2026

Bronstein, Gewirtz & Grossman LLC Urges Skye Bioscience, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Shareholders of Skye Bioscience, Inc. (SKYE): Protect Your Rights Before January 16, 2026 - Contact Levi & Korsinsky

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc.(SKYE) of a Class Action Lawsuit and an Upcoming Deadline

Skye Bioscience, Inc. (SKYE) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of January 16, 2026 Deadline

SKYE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Skye Bioscience, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity USA - English APAC - English APAC - Traditional Chinese

Class Action Filing Initiated by Pomerantz LLP Against Skye Bioscience, Inc. – SKYE

Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity